<?xml version="1.0" encoding="UTF-8"?>
<p id="p0035">In 2016, there were urban yellow fever outbreaks in Angola and Democratic Republic of Congo, which resulted in vaccine shortage and emergent vaccination campaigns using only one-fifth of the regular vaccine dosage in high-risk populations (
 <xref rid="bib6" ref-type="bibr">Calisher and Woodall, 2016</xref>). In late 2017 and early 2018, there was another urban outbreak in Brazil. While the number of yellow fever cases are significantly underreported due to the undeveloped nature of many endemic areas, it is estimated that up to 1.7 million YFV infections occur in Africa each year resulting in 29,000â€“60,000 deaths (
 <xref rid="bib8" ref-type="bibr">Douam and Ploss, 2018</xref>). This outnumbers the estimated death toll of global dengue virus infection (
 <ext-link ext-link-type="uri" xlink:href="http://www.who.int/mediacentre/factsheets/fs100/en/" id="intref0010" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.who.int/mediacentre/factsheets/fs100/en/</ext-link>). The World Health Organization and its partners responded to these recent outbreaks of yellow fever and emphasized the importance of additional research and the development of new vaccines, diagnostics and therapeutics as countermeasures (
 <ext-link ext-link-type="uri" xlink:href="http://www.who.int/emergencies/yellow-fever/response/en/" id="intref0015" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.who.int/emergencies/yellow-fever/response/en/</ext-link>).
</p>
